⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—Nippon India Consumption Fund - Growth - Direct PlanDirect · Growth
₹204.46 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFNippon India Consumption Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Sectoral Fund - ConsumptionEquity - Sectoral Fund - Pharma & Health Care
NAV₹204.46 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★
BenchmarkNifty India Consumption - TRIBSE Health Care - TRI
Fund ManagerKinjal DesaiNikhil Mathur
Inception01 Jan 201304 Oct 2023
Returns
1Y-11.62%22.64%
3Y8.51%30.41%
5Y10.84%—
Since Inception12.66%29.15%
Risk
14.9714.07
0.980.59
0.191.59
-1.4921.67
0.333.48
-11.97%-9.23%
Costs
Expense Ratio0.90%1.03%
Exit Load1% on or before 1M, Nil after 1M1% on or before 30D, Nil after 30D
Min SIP₹100₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Nippon India …100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between Nippon India Consumption Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →